A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
Saved in:
| Title: | A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer. |
|---|---|
| Authors: | Werner TL; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Ray A; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Lamb JG; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., VanBrocklin M; Department of Surgery, University of Utah, Salt Lake City, UT., Hueftle K; Department of Medicine, University of Utah, Salt Lake City, UT., Cohen AL; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Beck AC; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Buys SS; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT., Dyess DL; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL., Butler TW; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL., Dumlao TL; Banner M.D. Anderson Cancer Center, Gilbert, AZ., Neumayer L; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of Arizona, Tucson, AZ., Khong HT; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL; Department of Breast Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: hung.khong@moffitt.org. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2017 Nov; Vol. 17 (7), pp. 503-509. Date of Electronic Publication: 2017 Apr 29. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28579139 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Werner+TL%22">Werner TL</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Ray+A%22">Ray A</searchLink>; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Lamb+JG%22">Lamb JG</searchLink>; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22VanBrocklin+M%22">VanBrocklin M</searchLink>; Department of Surgery, University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Hueftle+K%22">Hueftle K</searchLink>; Department of Medicine, University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Cohen+AL%22">Cohen AL</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Beck+AC%22">Beck AC</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Buys+SS%22">Buys SS</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Dyess+DL%22">Dyess DL</searchLink>; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL.<br /><searchLink fieldCode="AU" term="%22Butler+TW%22">Butler TW</searchLink>; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL.<br /><searchLink fieldCode="AU" term="%22Dumlao+TL%22">Dumlao TL</searchLink>; Banner M.D. Anderson Cancer Center, Gilbert, AZ.<br /><searchLink fieldCode="AU" term="%22Neumayer+L%22">Neumayer L</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of Arizona, Tucson, AZ.<br /><searchLink fieldCode="AU" term="%22Khong+HT%22">Khong HT</searchLink>; Oncology Division, Department of Medicine, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Department of Surgery, University of South Alabama, Mitchell Cancer Institute, Mobile, AL; Department of Breast Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: hung.khong@moffitt.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100898731%22">Clinical breast cancer</searchLink> [Clin Breast Cancer] 2017 Nov; Vol. 17 (7), pp. 503-509. <i>Date of Electronic Publication: </i>2017 Apr 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100898731 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215268209%22">15268209 </searchLink><i>NLM ISO Abbreviation: </i>Clin Breast Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28579139 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clbc.2017.04.010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 503 Titles: – TitleFull: A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Werner TL – PersonEntity: Name: NameFull: Ray A – PersonEntity: Name: NameFull: Lamb JG – PersonEntity: Name: NameFull: VanBrocklin M – PersonEntity: Name: NameFull: Hueftle K – PersonEntity: Name: NameFull: Cohen AL – PersonEntity: Name: NameFull: Beck AC – PersonEntity: Name: NameFull: Buys SS – PersonEntity: Name: NameFull: Dyess DL – PersonEntity: Name: NameFull: Butler TW – PersonEntity: Name: NameFull: Dumlao TL – PersonEntity: Name: NameFull: Neumayer L – PersonEntity: Name: NameFull: Khong HT IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2017 Nov Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1938-0666 Numbering: – Type: volume Value: 17 – Type: issue Value: 7 Titles: – TitleFull: Clinical breast cancer Type: main |
| ResultId | 1 |